Interest Rate, Foreign Exchange Rate and Share Price Fluctuation Risk
First written in FY2016. 7 of 29 entries say "Worsened", first in FY2019. Latest entry: FY2026.
The Awa Bank moved to the "Worse" side of this theme in 2022, 3 years after the typical company in this theme (2019).
The whole theme swung hardest in 2019: 13 of 16 companies on the "Worse" side.
2 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「At the end of the fiscal year, total market risk exposure (estimated loss) was ¥135,204 million, compared with ¥113,676 million at the end of the previous fiscal year.」
Estimated market risk exposure increased from ¥113,676 million to ¥135,204 million. Meanwhile, gains on securities valuation increased to ¥184,400 million, showing both improved market conditions and higher risk exposure. - FY2026-H1Increase in valuation gains continuesAnnual report
「In addition, gains and losses on securities valuation increased by ¥30,400 million from the end of the previous fiscal year, mainly due to rising share prices and other factors, resulting in valuation gains of ¥142,800 million.」
Gains on securities valuation increased by ¥30,400 million from the end of the previous fiscal year to ¥142,800 million, mainly due to rising share prices and other factors. - FY2025-H1Increase in valuation gains continuesAnnual report
「Meanwhile, gains and losses on securities valuation increased by ¥10,000 million from the end of the previous fiscal year, mainly due to rising share prices and other factors, resulting in valuation gains of ¥135,800 million.」
Gains on securities valuation increased by ¥10,000 million from the end of the previous fiscal year to ¥135,800 million, mainly due to rising share prices and other factors. Valuation gains continued to improve as a result of market conditions. - FY2024Higher valuation gains alongside higher market risk exposureAnnual report
「At the end of the fiscal year, total market risk exposure (estimated loss) was ¥76,579 million, compared with ¥68,301 million at the end of the previous fiscal year. In addition, gains and losses on securities valuation increased by ¥63,300 million from the end of the previous fiscal year, resulting in valuation gains of ¥125,800 million.」
Gains on securities valuation increased significantly, while estimated market risk exposure increased from ¥68,300 million to ¥76,600 million. The disclosure shows both an improvement in market conditions and an increase in risk exposure. - FY2024-Q3Higher valuation gains alongside higher funding costs and impairment lossesAnnual report
「Net interest income and other income for the first nine months of the current fiscal year increased, including interest income on loans and interest and dividends on securities, but funding costs also increased, resulting in a ¥394 million year-on-year decrease to ¥26,721 million. Impairment losses recorded during the first nine months of the current fiscal year totaled ¥256 million, including ¥211 million on shares and ¥44 million on corporate bonds.」
Net interest income and other income decreased by ¥394 million year on year because funding costs increased, while the valuation difference on other securities increased from ¥62,460 million at the end of March 2023 to ¥91,996 million. Improved gains on securities valuation coexisted with higher funding costs and impairment losses. - FY2024-Q2Higher valuation gains alongside higher funding costs and securities impairmentAnnual report
「In addition, gains and losses on securities valuation increased by ¥21,700 million from the end of the previous fiscal year, resulting in valuation gains of ¥84,100 million. Net interest income and other income for the first half of the current fiscal year increased, including interest income on loans, but funding costs also increased, resulting in a ¥576 million year-on-year decrease in net interest income and other income to ¥17,873 million. Impairment losses recorded during the current interim consolidated accounting period totaled ¥261 million, including ¥261 million on shares and ¥0 million on corporate bonds.」
Gains on securities valuation increased by ¥21,700 million, while net interest income and other income decreased by ¥576 million because funding costs increased. An impairment loss of ¥261 million was also recorded on shares. The impact of market conditions was reflected in both improvements and deterioration. - FY2024-Q1Higher valuation gains alongside higher funding costsAnnual report
「In addition, ordinary expenses increased by ¥852 million from the first quarter of the previous fiscal year to ¥14,957 million, mainly due to higher funding costs resulting from rising overseas interest rates. Total 855,585 918,046 62,460 896,904 990,102 93,197」
Funding costs increased as overseas interest rates rose, and the impact of interest-rate movements was reflected in the results. Meanwhile, the valuation difference on other securities increased from ¥62,460 million at the end of the previous fiscal year to ¥93,197 million. - FY2023-Q3WorsenedAnnual report
「Valuation difference on other securities 58,375 36,005」
The valuation difference on other securities decreased from ¥58,375 million to ¥36,005 million, and the deterioration in valuation conditions caused by market conditions continued. - FY2023-Q2WorsenedAnnual report
「In addition, gains and losses on securities valuation decreased by ¥22,500 million from the end of the previous fiscal year, resulting in valuation gains of ¥62,800 million.」
Against a backdrop of rising overseas interest rates and a decline in foreign securities, gains on securities valuation decreased by ¥22,500 million from the end of the previous fiscal year. - FY2023-Q1WorsenedAnnual report
「Although the Company sought to manage its securities portfolio efficiently while giving priority to safety and liquidity, securities decreased by ¥20,300 million from the end of the previous fiscal year to ¥1,011.4 billion, mainly because foreign bonds and other assets declined.」
The securities balance decreased by ¥20,300 million from the end of the previous fiscal year because foreign bonds and other assets declined. The valuation difference on other securities also decreased from ¥58,375 million to ¥51,187 million. - FY2022WorsenedAnnual report
「At the end of the fiscal year, gains and losses on securities valuation decreased by ¥21,300 million from the end of the previous fiscal year to valuation gains of ¥85,400 million, mainly because foreign securities declined amid rising overseas interest rates.」
Gains on securities valuation decreased by ¥21,300 million from the end of the previous fiscal year amid rising overseas interest rates and other factors. Market risk exposure was ¥71,980 million, a slight decrease from ¥72,216 million at the end of the previous fiscal year. - FY2022-Q3Decrease in Valuation DifferenceAnnual report
「Valuation difference on other securities 73,194 70,246」
The valuation difference on other securities decreased from ¥73,194 million at the end of the previous fiscal year to ¥70,246 million at the end of December 2021. - FY2022-Q2Increase in valuation gains continuesAnnual report
「In addition, gains and losses on securities valuation increased by ¥7,900 million from the end of the previous fiscal year, resulting in valuation gains of ¥114,700 million.」
Gains on securities valuation increased by ¥7,900 million from the end of the previous fiscal year to ¥114,700 million. The valuation difference on other securities also increased from ¥73,194 million to ¥78,739 million. - FY2022-Q1Increase in valuation differencesAnnual report
「Valuation difference on other securities 73,194 76,221」
The valuation difference on other securities increased from ¥73,194 million at the end of the previous fiscal year to ¥76,221 million. - FY2021-Q3MitigatedAnnual report
「Total 924,118 983,933 59,814 900,024 996,010 95,986」
The valuation difference on other securities increased from ¥59,814 million at the end of the previous fiscal year to ¥95,986 million at the end of the third quarter, indicating an improvement in valuation conditions. - FY2021-Q2MitigatedAnnual report
「In addition, gains and losses on securities valuation increased by ¥29,700 million from the end of the previous fiscal year, resulting in valuation gains of ¥89,500 million.」
Gains on securities valuation increased from ¥59,800 million at the end of the previous fiscal year to ¥89,500 million, indicating an improvement in valuation conditions as market conditions recovered. - FY2021-Q1MitigatedAnnual report
「Securities increased by ¥12,700 million from the end of the previous fiscal year to ¥1,008.1 billion, mainly because their fair value increased as the market recovered.」
The disclosure states that fair values increased as the market recovered, and the valuation difference on other securities also increased from ¥59,814 million to ¥88,517 million. - FY2020WorsenedAnnual report
「At the end of the fiscal year, total market risk exposure (estimated loss) was ¥69,769 million, compared with ¥45,648 million at the end of the previous fiscal year.」
The estimated market risk exposure increased from ¥45,648 million to ¥69,769 million. Gains on securities valuation also decreased to ¥59,800 million. - FY2020-Q3Increase in valuation differenceAnnual report
「Valuation difference on other securities 65,837 73,698」
The valuation difference on other securities increased from ¥65,837 million at the end of the previous fiscal year to ¥73,698 million. - FY2020-Q2Increase in valuation gainsAnnual report
「In addition, gains and losses on securities valuation increased by ¥4,100 million from the end of the previous fiscal year, resulting in valuation gains of ¥100,600 million.」
Gains on securities valuation increased by ¥4,100 million from the end of the previous fiscal year to ¥100,600 million. The valuation difference, which had declined through the previous quarter, turned upward in the current interim period. - FY2020-Q1Decline in valuation differencesAnnual report
「Valuation difference on other securities 65,837 58,229」
The valuation difference on other securities decreased from ¥65,837 million at the end of the previous fiscal year to ¥58,229 million. - FY2019WorsenedAnnual report
「At the end of the fiscal year, total market risk exposure (estimated loss) was ¥45,648 million, compared with ¥33,753 million at the end of the previous fiscal year.」
The estimated market risk exposure increased from ¥33,753 million to ¥45,648 million. Gains on securities valuation also decreased by ¥8,800 million year on year. - FY2019-Q3Decline in valuation differencesAnnual report
「Valuation difference on available-for-sale securities ¥71,624 million ¥62,842 million」
Valuation difference on available-for-sale securities decreased from ¥71,624 million at the end of the previous consolidated fiscal year to ¥62,842 million, and the decline in unrealized gains continued. - FY2019-Q2Continued decrease in unrealized gainsAnnual report
「Unrealized gains on securities decreased by ¥900 million from the end of the previous consolidated fiscal year to ¥104.3 billion.」
Unrealized gains on securities remained at ¥104.3 billion, but decreased by ¥900 million from the end of the previous consolidated fiscal year. - FY2018MitigatedAnnual report
「At the end of the current consolidated fiscal year, total market risk, an estimate of the amount of loss, was ¥33,753 million, compared with ¥46,630 million at the end of the previous consolidated fiscal year.」
The estimated market risk amount decreased from ¥46,630 million to ¥33,753 million. Meanwhile, unrealized gains on securities amounted to ¥105.2 billion, down ¥200 million from the previous fiscal year. - FY2018-Q2Decrease in unrealized gainsAnnual report
「Unrealized gains on securities decreased by ¥8.0 billion from the end of the previous consolidated fiscal year to ¥97.4 billion.」
Unrealized gains on securities remained at ¥97.4 billion, although they decreased by ¥8.0 billion from the end of the previous consolidated fiscal year. No material change in market risk itself was reported. - FY2017MitigatedAnnual report
「At the end of the current consolidated fiscal year, total market risk, an estimate of the amount of loss, was ¥46,630 million, compared with ¥47,935 million at the end of the previous consolidated fiscal year.」
The estimated market risk amount decreased from ¥47,935 million at the end of the previous consolidated fiscal year to ¥46,630 million. - FY2017-Q2RestatedAnnual report
「Financial and foreign exchange markets remained volatile against the backdrop of developments in monetary policy in Japan and the United States and the outcome of the UK's referendum on leaving the EU, with the yen's appreciation and declining share prices continuing. Long-term interest rates generally remained in negative territory as the Bank of Japan continued its aggressive monetary easing policy.」
Market conditions, including monetary policy, yen appreciation, declining share prices and negative interest rates, continue to be described. - FY2016First statedAnnual report
「However, if unexpected increases in interest rates, declines in share prices or other events occur in the future, valuation losses or impairment losses may arise on securities held, potentially adversely affecting the operating results and financial position of the Group.」
Market risk is described as the risk of valuation losses or impairment losses on securities arising from fluctuations in interest rates, foreign exchange rates, share prices and other factors. The disclosed market risk amount is ¥47,935 million.